{
  "meta": {
    "title": "14_The_Parathyroids",
    "url": "https://brainandscalpel.vercel.app/14-the-parathyroids-89564ae7.html",
    "scrapedAt": "2025-11-30T12:35:49.083Z"
  },
  "questions": [
    {
      "text": "While performing a subtotal thyroidectomy, accidental ligation of which artery can potentially lead to hypoparathyroidism?",
      "choices": [
        {
          "id": 1,
          "text": "Superior thyroid artery"
        },
        {
          "id": 2,
          "text": "Inferior thyroid artery"
        },
        {
          "id": 3,
          "text": "Ascending cervical artery"
        },
        {
          "id": 4,
          "text": "Ascending pharyngeal artery"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Truncal ligation</strong> of the <strong>inferior thyroid artery</strong> can potentially result in <strong>hypoparathyroidism</strong>.&nbsp;Both&nbsp;superior and inferior<strong> parathyroid glands</strong> receive their blood from the inferior thyroid artery&nbsp;which arises from the subclavian arteries.Hence during thyroidectomy, only capsular branches closer to the thyroid gland should be ligated.</p>\n<p>The <strong>inferior</strong> parathyroid glands may have a <strong>variable blood supply</strong>, from either the ascending branch of the inferior thyroid arteries or the thyroid ima artery.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d6463da8cf984cbe89b73c1f2ae8a44ex1279x1337.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Blood Supply to the Thyroid Gland</h3><p><strong>Arterial supply of the thyroid gland</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vessel</strong></p>\n</td>\n<td>\n<p><strong>Origin</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superior thyroid artery</p>\n</td>\n<td>\n<p>External carotid artery</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inferior thyroid artery</p>\n</td>\n<td>\n<p>Thyrocervical trunk (1<sup>st</sup> part of Subclavian artery)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Arteria thyroidea ima</p>\n</td>\n<td>\n<p>Brachiocephalic trunk/arch of aorta</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Inferior thyroid artery supplies the parathyroid gland</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e0f52063eae64ee5a81910c4c655d1c6x1279x1337.JPEG\" alt=\"Pearl Image\"><p><strong>Venous drainage of the thyroid gland</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vessel</strong></p>\n</td>\n<td>\n<p><strong>Origin</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Superior and middle thyroid veins</p>\n<p>4th vein of Kocher (if present)</p>\n</td>\n<td>\n<p>Tributary of internal jugular vein</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inferior thyroid vein</p>\n</td>\n<td>\n<p>Tributary of brachiocephalic vein</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b211c9cc0d374685bb8d4da175f209dfx1279x1337.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3539",
      "difficulty": "easy"
    },
    {
      "text": "Identify the correct pair based on their embryological development.",
      "choices": [
        {
          "id": 1,
          "text": "Thymus, Inferior parathyroid gland - Third pharyngeal pouch"
        },
        {
          "id": 2,
          "text": "Thymus, Superior parathyroid gland - Fourth pharyngeal pouch"
        },
        {
          "id": 3,
          "text": "Superior and Inferior parathyroid gland - Third pharyngeal arch"
        },
        {
          "id": 4,
          "text": "Thymus, Superior parathyroid gland - Fourth pharyngeal arch"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>thymus</strong> and <strong>inferior parathyroid glands</strong> originate from the <strong>third pharyngeal pouch</strong>. They migrate from the upper neck to the mediastinum during embryonic development. Inferior parathyroid glands have more variation in their anatomical position due to a long descent.</p>\n<p>The <strong>superior parathyroid glands</strong> originate from the <strong>fourth pharyngeal pouch</strong>. They are more constant in their position.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4e723d93b507470ebeb71887613a5d94x1280x1407.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Derivatives of Branchial Apparatus</h3><table>\n<tbody>\n<tr>\n<td>Arch</td>\n<td>Nerve</td>\n<td>Skeletal derivatives</td>\n<td>Pouch Derivatives</td>\n<td>Muscle Derivatives</td>\n<td>Artery&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>1st (mandibular arch)</p>\n</td>\n<td>Trigeminal (V) - Maxillary and mandibular divisions</td>\n<td>\n<ul>\n<li>Incus</li>\n<li>Malleus</li>\n<li>Anterior ligament of malleus</li>\n<li>Spine of sphenoid</li>\n<li>Sphenomandibular ligament&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Auditory tube</li>\n<li>Middle ear cavity&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Tensor tympani</li>\n<li>Muscles of mastication&nbsp;</li>\n<li>Mylohyoid</li>\n<li>Anterior belly of digastric</li>\n<li>Tensor veli palatini</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Maxillary artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>2nd (hyoid arch)</p>\n</td>\n<td>Facial (VII)</td>\n<td>\n<ul>\n<li>Stapes</li>\n<li>Styloid process (temporal)</li>\n<li>Lesser cornu and upper hyoid</li>\n<li>Stylohyoid ligament</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Palatine tonsil</li>\n<li>Tonsillar fossa&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stapedius</li>\n<li>Stylohyoid&nbsp;</li>\n<li>Facial Muscles (Buccinator, Platysma, Posterior belly of digastric)</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stapedial artery</li>\n<li>Hyoid artery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>3rd</td>\n<td>Glossopharyngeal (IX)</td>\n<td>\n<ul>\n<li>Greater cornu of hyoid</li>\n<li>Lower part of hyoid body</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Inferior parathyroids</li>\n<li>Thymus&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Stylopharyngeus</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Common carotid</li>\n<li>Proximal internal carotid arteries&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>4th</td>\n<td>Superior laryngeal of Vagus (X)</td>\n<td>\n<ul>\n<li>Thyroid cartilage</li>\n<li>Corniculate cartilage</li>\n<li>Cuneiform cartilage&nbsp;</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Superior parathyroids,</li>\n<li>Parafollicular C cells of Thyroid (from ultimobranchial body)</li>\n</ul>\n&nbsp;</td>\n<td><br />\n<ul>\n<li>Pharyngeal muscles</li>\n<li>Larynx -Cricothyroid</li>\n<li>Levator veli palatini</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Right side:&nbsp;Right subclavian artery (proximal portion)</li>\n</ul>\n<ul>\n<li>Left side:&nbsp;Arch of the aorta from the left common carotid to the left subclavian arteries</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>6th</td>\n<td>Recurrent laryngeal of Vagus (X)</td>\n<td>\n<ul>\n<li class=\"p1\">Arytenoid cartilages</li>\n</ul>\n&nbsp;</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>All intrinsic muscles of the larynx (except the cricothyroid muscle)</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Right side: right pulmonary artery&nbsp;</li>\n<li>Left side: left pulmonary artery and ductus arteriosus</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3540",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common site of ectopic parathyroid gland?",
      "choices": [
        {
          "id": 1,
          "text": "Mediastinal"
        },
        {
          "id": 2,
          "text": "Intrathyroidal"
        },
        {
          "id": 3,
          "text": "Intrathymic"
        },
        {
          "id": 4,
          "text": "Paraesophageal"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>most common</strong> site of the <strong>ectopic parathyroid gland</strong>&nbsp;is <strong>paraesophageal</strong>.</p>\n<p>The common sites of ectopic parathyroid glands are</p>\n<ul>\n<li>Paraesophageal - most common</li>\n<li aria-level=\"1\">Mediastinal&nbsp;</li>\n<li aria-level=\"1\">Intrathymic&nbsp;</li>\n<li aria-level=\"1\">Intrathyroidal&nbsp;</li>\n<li aria-level=\"1\">Carotid sheath&nbsp;</li>\n<li aria-level=\"1\">High cervical or undescended&nbsp;</li>\n</ul>\n<p>Ectopic parathyroid is the most common cause of <strong>persistent </strong>or<strong> recurrent hyperparathyroidism</strong>. In such cases, treatment involves <strong>surgical removal</strong> of the gland.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ee5f3098a3542bdb637c0d81234d267x1279x1485.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4712",
      "difficulty": "hard"
    },
    {
      "text": "What is the most common cause of hypercalcemia in hospitalized patients?",
      "choices": [
        {
          "id": 1,
          "text": "Hypervitaminosis D"
        },
        {
          "id": 2,
          "text": "Malignancy"
        },
        {
          "id": 3,
          "text": "Parathyroid adenoma"
        },
        {
          "id": 4,
          "text": "Parathyroid hyperplasia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Cancer</strong> is the most common cause of <strong>hypercalcemia</strong> in <strong>hospitalized patients</strong>, whereas hyperparathyroidism is the most common cause of hypercalcemia detected incidentally in outpatients. The causes of hypercalcemia in cancer : </p>\n<ul>\n<li aria-level=\"1\">Cancers affecting <strong>bone </strong>like multiple myeloma, leukemia, bony metastasis - cause the bone to break down which <strong>releases excess calcium</strong> into the blood</li>\n<li aria-level=\"1\"><strong>Pseudohyperparathyroidism</strong> - tumours producing parathyroid hormone-related peptide <strong>(PTHrP)</strong> cause the bone to release calcium into the blood. The most common carcinoma associated is squamous cell carcinoma of lung.</li>\n<li aria-level=\"1\">Cancers affecting <strong>kidneys</strong> - failure to remove excess calcium from the blood</li>\n<li aria-level=\"1\"><strong>Dehydration</strong> caused by nausea and vomiting - difficult for the kidneys to remove calcium from the blood properly</li>\n<li aria-level=\"1\"><strong>Lack </strong>of<strong> physical activity</strong> - causes bone breakdown, releasing calcium into the blood</li>\n</ul><hr><h3>Related Pearl: Causes of Hypercalcemia</h3><ul>\n<li><strong>Parathyroid</strong>-Related\n<ul>\n<li>Primary hyperparathyroidism\n<ul>\n<li>Adenoma(s)</li>\n<li>Multiple endocrine neoplasia</li>\n<li>Carcinoma</li>\n</ul>\n</li>\n<li>Lithium therapy</li>\n<li>Familial hypocalciuric hypercalcemia</li>\n</ul>\n</li>\n<li><strong>Malignancy</strong>-Related\n<ul>\n<li>Solid tumour with metastases (breast)</li>\n<li>Solid tumour with humoral mediation of hypercalcemia (lung, kidney)</li>\n<li>Hematologic malignancies (multiple myeloma, lymphoma, leukemia)</li>\n</ul>\n</li>\n<li><strong>Vitamin</strong> <strong>D</strong>&ndash;Related\n<ul>\n<li>Vitamin D intoxication</li>\n<li>&uarr; 1,25(OH)2D :\n<ul>\n<li>Sarcoidosis and other granulomatous diseases</li>\n<li>Impaired 1,25(OH)2D metabolism due to 24-hydroxylase deficiency</li>\n</ul>\n</li>\n<li>Associated with <strong>high bone turnover</strong>\n<ul>\n<li>Hyperthyroidism</li>\n<li>Immobilization</li>\n<li>Thiazides</li>\n<li>Vitamin A intoxication</li>\n<li>Fat necrosis</li>\n</ul>\n</li>\n<li>Associated with <strong>renal failure</strong>\n<ul>\n<li>Severe secondary hyperparathyroidism</li>\n<li>Aluminium intoxication</li>\n<li>Milk-alkali syndrome</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4718",
      "difficulty": "hard"
    },
    {
      "text": "What is the most common cause of primary hyperparathyroidism?",
      "choices": [
        {
          "id": 1,
          "text": "Single adenoma"
        },
        {
          "id": 2,
          "text": "Multiple adenoma"
        },
        {
          "id": 3,
          "text": "Hyperplasia"
        },
        {
          "id": 4,
          "text": "Carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A<strong> single adenoma</strong> is the <strong>most common</strong> cause of <strong>primary hyperparathyroidism</strong>. They are most often located in the inferior parathyroid glands.</p>\n<p>Primary hyperparathyroidism is due to <strong>excess </strong>or<strong> non-suppressed PTH</strong> secretion from the following:</p>\n<ul>\n<li aria-level=\"1\">Single parathyroid adenoma&nbsp;</li>\n<li aria-level=\"1\">Multiple adenomas&nbsp;</li>\n<li aria-level=\"1\">Hyperplasia&nbsp;</li>\n<li aria-level=\"1\">Carcinoma&nbsp;</li>\n</ul>\n<p><strong>Sporadic</strong> primary hyperparathyroidism (<strong>HPT</strong>) is <strong>more common</strong> than familial (MEN syndrome/ familial HPT/ Familial HPT with jaw tumor syndrome). <strong>Women</strong> are affected more commonly than men.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4714",
      "difficulty": "easy"
    },
    {
      "text": "Lab investigations in a patient with fatigue and colicky abdominal pains show elevated PTH and calcium, and low serum phosphate. Which of the following ophthalmic findings is pathognomonic of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Kayser Fleischer rings"
        },
        {
          "id": 2,
          "text": "Band keratopathy"
        },
        {
          "id": 3,
          "text": "Ocular chrysiasis"
        },
        {
          "id": 4,
          "text": "Hudson-Stahli line"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>primary hyperparathyroidism</strong>.<strong> Band keratopathy</strong> is pathognomonic of this condition.&nbsp;It is due to the deposition of <strong>calcium phosphate</strong> crystals in the cornea.&nbsp;</p>\n<p>In patients with elevated PTH, calcium and phosphate levels are measured. <strong>Elevated calcium</strong> and decreased phosphate levels are suggestive of <strong>primary</strong> hyperparathyroidism. <strong>Normal calcium</strong> and elevated phosphate levels are suggestive of <strong>secondary</strong> hyperparathyroidism.</p>\n<p>The image given below shows band keratopathy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4513eb0275e849ffbafce00501ec3d47x1280x960.JPEG\" alt=\"Explanation Image\"><p>Option A: Kayser Fleischer rings are brownish-yellow rings in the corneoscleral junction due to the deposition of <strong>copper</strong> in the cornea.&nbsp;</p>\n<p>Option C: Ocular chrysiasis is the deposition of gold in the cornea, after repeated parenteral administration of <strong>gold salts</strong>.&nbsp;</p>\n<p>Option D: Hudson Stahli line is a superficial brown line at the junction of the upper 2/3 and lower 1/3 of the cornea in an otherwise normal cornea. It is attributed to the deposition of <strong>iron</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3563",
      "difficulty": "easy"
    },
    {
      "text": "During a clinical trial, it was found that some individuals who showed radioactive uptake on Sestamibi scan, showed no other evidence of hyperparathyroidism. They were instead found to be suffering from a Hurthle cell nodule of the thyroid gland. Which of the following radioactive tracer tests could be used to rule out the false positives?",
      "choices": [
        {
          "id": 1,
          "text": "Ga-68 Dotatate"
        },
        {
          "id": 2,
          "text": "Iodine-131 MIBG"
        },
        {
          "id": 3,
          "text": "Tc-99m Pertechnetate"
        },
        {
          "id": 4,
          "text": "Tc-99m Medronate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>A thyroid-specific tracer like <strong>99Tc-Pertechnetate</strong> and subsequent subtraction images could be used to <strong>rule out</strong> the <strong>false positives</strong> caused by the solid thyroid nodules such as Hurthle cell nodule.</p>\n<p>The Sestamibi scanning is a nuclear-based imaging test used to<strong> localize the parathyroid glands</strong>. Sestamibi is a monovalent lipophilic cation that&nbsp;<strong>accumulates in mitochondria</strong>. Due to this, there is a difference in the rate at which it gets washed out depending upon the number of mitochondria in each tissue. <strong>Parathyroid adenomas</strong> often have a high concentration of <strong>oxyphilic cells</strong> with <strong>high mitochondrial content </strong>and they retain tracers and have a slower washout compared to the normal glands.</p>\n<p>In patients with nodular goiter or functional <strong>tumors of the thyroid gland</strong>, increased uptake of sestamibi by the thyroid gland makes parathyroid visualization difficult.&nbsp;There are two primary techniques to <strong>differentiate</strong> sestamibi uptake by abnormal parathyroid and thyroid tissue:</p>\n<ul>\n<li><strong>Dual-isotope subtraction imaging&nbsp;</strong>(with sestamibi and either iodine-123 or 99mTc pertechnetate)<strong>&nbsp;-&nbsp;&nbsp;<sup>99m</sup>Tc pertechnetate </strong>is taken up only by the<strong> thyroid. </strong>The&nbsp;<sup>99m</sup>Tc pertechnetate scintigram is then digitally subtracted from the sestamibi scan&nbsp;to allow parathyroid localization.</li>\n<li><strong>Single-isotope dual-phase</strong> imaging (with sesta&shy;mibi alone with early and delayed imaging)<strong>&nbsp;- </strong>since the rate of washout from the hyperfunctioning parathyroid gland is slower when compared to the thyroid gland.</li>\n</ul>\n<p>The image given below shows the dual-isotope subtraction imaging.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b76161fc238044019b534813a8a69201x290x276.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Radionuclide agents and their uses</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Radionuclide agent</strong></p>\n</td>\n<td>\n<p><strong>Use</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Medronate (MDP) (most common)</p>\n<p>Tc-99m Oxidronate (HMDP)</p>\n<p>Tc-99m HEDP</p>\n</td>\n<td>\n<p>Bone imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Apcitide</p>\n</td>\n<td>\n<p>Peptide imaging of DVT</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Arcitumomab</p>\n</td>\n<td>\n<p>Monoclonal antibody for colorectal cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m albumin colloid</p>\n</td>\n<td>\n<p>Imaging of RES (liver/spleen)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m bicisate (ECD)</p>\n<p>Tc-99m exametazine (HMPAO</p>\n</td>\n<td>\n<p>Cerebral perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Depreotide</p>\n</td>\n<td>\n<p>Somatostatin receptor-bearing pulmonary masses</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m disofenin (DISIDA)</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Glucepatate</p>\n<p>Tc-99m Meriatide</p>\n<p>Tc-99m Succimer (DMSA)</p>\n</td>\n<td>\n<p>Renal imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Human Serum Albumin(HAS)</p>\n</td>\n<td>\n<p>Imaging of cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Lidofenin (HIDA)</p>\n<p>Tc-99m Mebrofenin</p>\n</td>\n<td>\n<p>Hepatobiliary imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m nofetumomab Merpentan NR-LU-10</p>\n</td>\n<td>\n<p>Monoclonal antibody Fab fragment for imaging small cell lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pentetate (DTPA)</p>\n</td>\n<td>\n<p>Renal imaging and functional studies; radioaerosol ventilation imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Pyrophosphate (PYP)</p>\n</td>\n<td>\n<p>Avid infarct imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Red Blood Cells (RBCs)</p>\n</td>\n<td>\n<p>Imaging of GI bleeds, cardiac chambers</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sestamibi</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging; breast tumor imaging, parathyroid gland</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Sulfur colloid (SC)</p>\n</td>\n<td>\n<p>Imaging of RES( liver/spleen), gastric emptying, GI bleeds</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tc-99m Teboroxime</p>\n<p>Tc-99m Tetrofosmin</p>\n</td>\n<td>\n<p>Myocardial perfusion imaging</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><sup>68</sup>Gallium</p>\n</td>\n<td>\n<p>Binds to somatostatin receptors</p>\n<p>Detection of new neuroendocrine tumors</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3565",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with polyuria, polydipsia, lethargy and abdominal pain. He had an X-ray taken a few days ago, which is given below. Which of the following investigations would not be useful in arriving at a diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Nuclear sestamibi scan"
        },
        {
          "id": 2,
          "text": "Ultrasonography of neck"
        },
        {
          "id": 3,
          "text": "Dual-energy radiographic absorptiometry"
        },
        {
          "id": 4,
          "text": "Angiography of renal arteries"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario with the X-ray showing <strong>nephrocalcinosis</strong> is suggestive of <strong>primary hyperparathyroidism</strong>. <strong>Angiography of renal arteries</strong> is not a useful investigation for hyperparathyroidism. <strong> </strong></p>\n<p>Nephrocalcinosis occurs in this condition due to hypercalcemia. It decreases renal concentrating ability, which may cause polyuria and polydipsia.</p>\n<p><strong>Clinical features</strong> of hyperparathyroidism:</p>\n<ul>\n<li aria-level=\"1\">Bones:</li>\n<ul>\n<li aria-level=\"2\">Pathological fractures</li>\n<li aria-level=\"2\">Subperiosteal bone resorption - 2nd and 3rd digits, most common in radial aspect</li>\n<li aria-level=\"2\">Salt and pepper skull</li>\n<li aria-level=\"2\">Osteitis fibrosa cystica or VonReckling Hausen’s disease of bone</li>\n</ul>\n</ul>\n<ul>\n<li aria-level=\"1\">Stones\n<ul>\n<li aria-level=\"2\">Multiple and recurrent renal stones - most common</li>\n<li aria-level=\"2\">Nephrocalcinosis</li>\n</ul>\n</li>\n<li aria-level=\"1\">Abdominal groans - colicky due to pancreatitis</li>\n<li aria-level=\"1\">Psychiatric overtones - raised PTH causing CNS depression and psychiatric symptoms</li>\n<li aria-level=\"1\">Band keratopathy</li>\n<li aria-level=\"1\">Features of hypercalcemia - \n<ul>\n<li aria-level=\"1\">Vomiting</li>\n<li aria-level=\"1\">Confusion</li>\n<li aria-level=\"1\">ECG changes: increased PR interval, shortened QT interval</li>\n</ul>\n</li>\n</ul>\n<p> The image given below shows salt and pepper skull seen in hyperparathyroidism.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a97f3a764664ddcab38ab9a33f0112ex672x526.JPEG\" alt=\"Explanation Image\"><p><strong>Investigations</strong> done in primary hyperparathyroidism:</p>\n<ul>\n<li><strong>Ultrasonography</strong> of the neck is a safe and widely used technique for the localization of abnormal parathyroid glands. <strong> </strong></li>\n<li>Nuclear medicine scanning with <strong>radiolabeled Sestamibi</strong> is also a widely used technique. Sestamibi accumulates in parathyroid adenomas. This radionuclide is concentrated in the thyroid and parathyroid tissue but usually washes out of normal thyroid tissue in under an hour. It persists in abnormal parathyroid tissue.  </li>\n<li><strong>Dual-energy radiographic absorptiometry</strong> is a useful tool to demonstrate skeletal involvement in primary hyperparathyroidism.</li>\n</ul>\n<p>The image given below shows a radiolabeled Sestamibi scan.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b7204f4e10a44f878b1d4145e1e53a47x512x512.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/871e7bbd04c04510b4729524de1f7c2e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6317",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with asymptomatic primary hyperparathyroidism, when will you perform parathyroidectomy?",
      "choices": [
        {
          "id": 1,
          "text": "If bone mineral density of  > 2.5 SD above peak bone mass"
        },
        {
          "id": 2,
          "text": "If age >50 years"
        },
        {
          "id": 3,
          "text": "In the presence of hypercalciuria but absence of nephrolithiasis"
        },
        {
          "id": 4,
          "text": "If creatinine clearance is reduced by 30%"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Reduction in creatinine clearance by 30%&nbsp;</strong>is an indication for parathyroidectomy in patients with asymptomatic primary hyperparathyroidism.</p><hr><h3>Related Pearl: Indications for parathyroidectomy in patients with asymptomatic primary HPT (2013-2014 NIH Consensus Conference Guidelines)</h3><ul>\n<li>Serum calcium &gt;1 mg/dL above the upper limit of normal</li>\n<li>Renal: <br />\n<ul>\n<li>Reduction in creatinine clearance by 30%</li>\n<li>24-h urine calcium &gt;400 mg/day</li>\n<li>Presence of nephrolithiasis or nephrocalcinosis</li>\n</ul>\n</li>\n<li>Skeletal: \n<ul>\n<li>Decreased bone mineral density (T score &lt;-2.5)</li>\n<li>Presence of vertebral fracture</li>\n</ul>\n</li>\n<li>Age &lt;50 years</li>\n</ul>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4725",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old lady with a history of multiple pathological fractures and renal stones was diagnosed with parathyroid hyperplasia involving all four glands. Which of the following treatment modalities will you use to treat her?",
      "choices": [
        {
          "id": 1,
          "text": "Complete removal of all four glands alone"
        },
        {
          "id": 2,
          "text": "Complete removal of three glands with a partial resection of the least affected gland"
        },
        {
          "id": 3,
          "text": "Partial resection of the affected glands with autotransplantation of the least affected gland"
        },
        {
          "id": 4,
          "text": "Brachytherapy with PTH supplementation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Hyperplasia involving all four parathyroid glands is treated by <strong>complete removal of three glands</strong> with <strong>partial resection of the least affected gland (Subtotal parathyroidectomy)</strong>. Total cervical parathyroidectomy with heterotropic transplantation can also be done in this patient.</p>\n<p>Modes of <strong>treatment</strong> for parathyroid hyperplasia:</p>\n<ol>\n<li><strong>Subtotal parathyroidectomy -</strong>&nbsp;The <strong>affected glands </strong>are <strong>completely removed</strong> and the <strong>least affected gland </strong>is<strong> partially resected</strong>. The remnants left behind should ideally be 30 mg. A lower gland is preferred because its location reduces the risk of injury to the recurrent laryngeal nerve.&nbsp;</li>\n<li><strong>Total parathyroidectomy</strong> with heterotopic transplantation - <strong>All 4 </strong>parathyroid glands are <strong>removed</strong> and parathyroid <strong>tissue</strong> is <strong>immediately transplanted</strong> to the non-dominant forearm. Pockets are made in the belly of the <strong>brachioradialis</strong> muscle, and one to two pieces of parathyroid tissue measuring 1 mm each are placed into each pocket. A total of 12 to 14 pieces are transplanted.</li>\n</ol>\n<p><strong>Complications</strong> of <strong>parathyroidectomy</strong> include:</p>\n<ul>\n<li>Persistent or recurrent hyperparathyroidism</li>\n<li>Hypoparathyroidism</li>\n<li>Hungry bone syndrome</li>\n<li>Injury to recurrent laryngeal nerve</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4722",
      "difficulty": "medium"
    },
    {
      "text": "Autotransplantation was done after total parathyroidectomy in a patient with hyperplasia of all 4 parathyroid glands. Which of the following best describes this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "Heterotopic"
        },
        {
          "id": 2,
          "text": "Orthotopic"
        },
        {
          "id": 3,
          "text": "Auxiliary"
        },
        {
          "id": 4,
          "text": "Isograft"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 348\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Parathyroid is transplanted&nbsp;<strong>heterotopically </strong>i.e.<strong>&nbsp;</strong>organ is implanted in another anatomic location.</p>\n<p>In&nbsp;total parathyroidectomy,&nbsp;all 4 parathyroid glands are removed&nbsp;and parathyroid tissue is&nbsp;immediately transplanted&nbsp;to the brachioradialis muscle in the non-dominant forearm.</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Types of transplants</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>&nbsp;Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Orthotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in the same anatomic location in the recipient as it was in the donor.&nbsp;Diseased organ is removed. Eg: heart, lung, liver, intestine</p>\n</td>\n</tr>\n<tr>\n<td><strong>Heterotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in a different anatomic location. Diseased organ is left in place. Eg: Kidney, pancreas</p>\n</td>\n</tr>\n<tr>\n<td><strong>Auxiliary transplantation</strong></td>\n<td>Partial tissue from the donor is used which acts as temporary support for the recipient's injured organ, which remains in place. Eg: left lobe of liver</td>\n</tr>\n<tr>\n<td><strong>Autotransplant&nbsp;</strong></td>\n<td>Transfer of cells/tissues/organs within the same person.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Allotransplant</strong></td>\n<td>Transfer of cells/tissues/organs within the same species.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Xenotransplant</strong></td>\n<td>Transfer of cells/tissues/organs in a different species.</td>\n</tr>\n<tr>\n<td><strong>Isograft</strong></td>\n<td>Transfer of organ or tissue within genetically identical individuals. Eg: Identical twins</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4183",
      "difficulty": "medium"
    },
    {
      "text": "Parathyroid gland post surgery  is commonly transferred to:",
      "choices": [
        {
          "id": 1,
          "text": "Triceps"
        },
        {
          "id": 2,
          "text": "Biceps"
        },
        {
          "id": 3,
          "text": "Sartorius"
        },
        {
          "id": 4,
          "text": "Brachioradialis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>parathyroid</strong> is commonly transferred to the <strong>brachioradialis</strong> muscle <strong>post-surgery</strong>. This will facilitate easy removal if there is disease recurrence after surgery.</p>\n<p>Parathyroidectomy is <strong>indicated</strong> in:</p>\n<ol>\n<li aria-level=\"1\"><strong>Symptomatic</strong> <strong>primary</strong> hyperparathyroidism <strong>(HPT)</strong>:&nbsp;&nbsp;</li>\n<li aria-level=\"1\"><strong>Asymptomatic</strong> primary HPT with:\n<ul>\n<li aria-level=\"1\">raise in serum calcium &gt;1mg/dl of the normal range</li>\n<li aria-level=\"1\">&gt;400 mg urinary calcium in 24-hour urine test</li>\n<li aria-level=\"1\">&lt; -2.5 Z-score of bone mineral density</li>\n<li aria-level=\"1\">Age &lt;50yr and failed medical treatment&nbsp;</li>\n</ul>\n</li>\n<li aria-level=\"1\"><strong>Severe cases</strong> of <strong>secondary</strong> HPT</li>\n</ol>\n<p>Parathyroidectomy is <strong>performed</strong> in neck hyperextension <strong>(semi-Fowler position)</strong>. The thyroid gland is mobilized, and the parathyroid gland with adenoma is identified and resected. The parathyroid tissue is <strong>transplanted</strong> to the <strong>non-dominant forearm</strong>.</p>\n<p>Pockets are made in the <strong>belly of the brachioradialis muscle</strong>, and one to two pieces of parathyroid tissue measuring 1 mm each are placed into each pocket. A total of 12 to 14 pieces are transplanted. This is a type of <strong>heterotopic transplant.</strong></p>\n<p><strong>Miami criteria</strong> (confirm the <strong>absence</strong> of another <strong>hyperactive parathyroid</strong>): A drop of parathyroid hormone intraoperatively, to <strong>more than half</strong> the maximum value at <strong>10 minutes </strong>postresection is considered an adequate resection in a parathyroid adenoma. However, if there is <strong>no drop</strong> in PTH level, then a <strong>multi-gland disease</strong> is suspected and the surgery is converted to a bilateral neck exploration.</p>\n<p>Complications of parathyroidectomy include:</p>\n<ol>\n<li aria-level=\"1\">Persistent or recurrent hyperparathyroidism</li>\n<li aria-level=\"1\">Hypoparathyroidism (presenting as hypocalcemia)</li>\n<li aria-level=\"1\">Hungry bone syndrome</li>\n<li aria-level=\"1\">Injury to the recurrent laryngeal nerve</li>\n</ol><hr><h3>Related Pearl: Types of transplants</h3><table>\n<tbody>\n<tr>\n<td><strong>Type</strong></td>\n<td><strong>&nbsp;Definition</strong></td>\n</tr>\n<tr>\n<td><strong>Orthotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in the same anatomic location in the recipient as it was in the donor.&nbsp;Diseased organ is removed. Eg: heart, lung, liver, intestine</p>\n</td>\n</tr>\n<tr>\n<td><strong>Heterotopic</strong></td>\n<td>\n<p class=\"p1\">Organ implanted in a different anatomic location. Diseased organ is left in place. Eg: Kidney, pancreas</p>\n</td>\n</tr>\n<tr>\n<td><strong>Auxiliary transplantation</strong></td>\n<td>Partial tissue from the donor is used which acts as temporary support for the recipient's injured organ, which remains in place. Eg: left lobe of liver</td>\n</tr>\n<tr>\n<td><strong>Autotransplant&nbsp;</strong></td>\n<td>Transfer of cells/tissues/organs within the same person.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Allotransplant</strong></td>\n<td>Transfer of cells/tissues/organs within the same species.&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Xenotransplant</strong></td>\n<td>Transfer of cells/tissues/organs in a different species.</td>\n</tr>\n<tr>\n<td><strong>Isograft</strong></td>\n<td>Transfer of organ or tissue within genetically identical individuals. Eg: Identical twins</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7507",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old woman presents with complaints of numbness around the lips and a tingling sensation in her fingers. She underwent parathyroidectomy for hyperparathyroidism one year ago. An ECG was done and is given below. What will be your immediate management?",
      "choices": [
        {
          "id": 1,
          "text": "Beta blockers"
        },
        {
          "id": 2,
          "text": "Teriparatide"
        },
        {
          "id": 3,
          "text": "IV Bisphosphonates"
        },
        {
          "id": 4,
          "text": "IV Calcium gluconate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario and ECG showing&nbsp;a <strong>prolonged QT interval</strong> (QT interval more than 0.43 seconds) is suggestive of <strong>hungry bone syndrome</strong> i.e.&nbsp;<strong>hypocalcemia</strong> post parathyroidectomy. Acute symptomatic presentation of hypocalcemia is treated with <strong>IV calcium gluconate.</strong></p>\n<p><strong>Symptoms and signs of hypocalcemia</strong>:</p>\n<ul>\n<li aria-level=\"1\">Mild circumoral or digital numbness</li>\n<li aria-level=\"1\">Paresthesia</li>\n<li aria-level=\"1\">Laryngeal spasms&nbsp;</li>\n<li aria-level=\"1\">Cardiac arrhythmias&nbsp;</li>\n<li aria-level=\"1\"><strong>Chvostek sign</strong>:&nbsp;This is elicited by gently tapping over the <strong>facial nerve</strong> in front of the<strong> tragus</strong> of the ear. There is hyperexcitability of the facial muscles, manifesting as a contraction of the muscles.</li>\n<li aria-level=\"1\"><strong>Trousseau's sign</strong>:&nbsp;This is elicited by making the forearm ischemic by applying a sphygmomanometer cuff to the arm and keeping the pressure <strong>above</strong> systolic blood pressure (<strong>SBP</strong>) for <strong>5 minutes</strong>. The hand goes into a painful carpopedal spasm and assumes the accoucheur&rsquo;s hand position. (shown in the image below)</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d4c48e73535461ab15bea1f0755d4d3x600x486.JPEG\" alt=\"Explanation Image\"><p>Acute symptomatic hypocalcemia is an emergency and must be treated with:</p>\n<ul>\n<li><strong>10 ml</strong> of <strong>10% calcium gluconate</strong> is given slowly through <strong>intravenous</strong> route</li>\n<li>Calcium and vitamin D replacement is given orally</li>\n<li>Magnesium supplementation may also be required due to the synergistic actions of calcium and magnesium</li>\n</ul>\n<p>The continuous need for calcium or vitamin D, 1-year postoperatively is called <strong>permanent hypoparathyroidism</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cc12d66e8e4a437e92e396317b308ba2.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3577",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false about secondary hyperparathyroidism?",
      "choices": [
        {
          "id": 1,
          "text": "Lithium intake may cause secondary hyperparathyroidism"
        },
        {
          "id": 2,
          "text": "Calciphylaxis is seen in early stages"
        },
        {
          "id": 3,
          "text": "Multiple gland affliction is common"
        },
        {
          "id": 4,
          "text": "Transcervical thymectomy is indicated"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Calciphylaxis</strong> (calcific uremic arteriolopathy) is a disseminated calcification seen <strong>late</strong> in the course of <strong>secondary hyperparathyroidism.</strong></p>\n<p>In calciphylaxis, the underlying calcification in the vascular and arteriolar walls&nbsp;&rarr;&nbsp;ischemic necrosis&nbsp;&rarr; ulceration and gangrene &rarr; sepsis &rarr; death.</p>\n<p>It presents as an <strong>expanding cutaneous lesion</strong> which is predominantly seen in the extremities and lower abdomen. Prognosis is poor and an <strong>urgent parathyroidectomy</strong> is shown to increase median survival.<strong><br /></strong></p>\n<p><strong>Causes of secondary hyperparathyroidism:</strong></p>\n<ul>\n<li aria-level=\"1\">Chronic renal failure (<strong>most common</strong>)</li>\n<li aria-level=\"1\">Vitamin D3 deficiency</li>\n<li aria-level=\"1\">GI malabsorption</li>\n<li aria-level=\"1\">Lithium intake</li>\n</ul>\n<p>To minimize the risk of missing parathyroid glands, <strong>transcervical</strong>&nbsp;<strong>thymectomy</strong> should be considered as a routine part of total parathyroidectomy with autotransplantation and subtotal parathyroidectomy. In addition, careful cervical exploration for secondary hyperparathyroidism should be carried out.</p>\n<p>The image below shows <strong>calciphylaxis</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f917645c8624c09b6f2543ad514d571x1280x805.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4723",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old patient with chronic renal failure presents to the OPD with complaints of recent onset pain in her feet. Blood investigation showed elevated PTH levels and normal serum calcium values. All of the following mechanisms contribute to elevated PTH in this patient except _____",
      "choices": [
        {
          "id": 1,
          "text": "Stimulation of parathyroid cells by hyperphosphatemia"
        },
        {
          "id": 2,
          "text": "Increased secretion of FGF-23 by osteocytes"
        },
        {
          "id": 3,
          "text": "Reduced expression of Vitamin D receptors and CaSR (calcium-sensing receptor) in bones"
        },
        {
          "id": 4,
          "text": "Interference with parathyroid kinase C signal transduction pathway and Wnt pathway"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario described here showing <strong>elevated PTH</strong> and <strong>normal calcium </strong>levels is that of <strong>secondary hyperparathyroidism</strong> due to renal failure. <strong>Interference</strong> with <strong>parathyroid kinase C</strong> signal transduction pathway and <strong>Wnt pathway</strong> is the proposed mechanism of secondary hyperparathyroidism in the setting of <strong>lithium consumption</strong> and not renal hyperparathyroidism.</p>\n<p>Causes for increased PTH in secondary hyperparathyroidism due to renal failure:</p>\n<ul>\n<li aria-level=\"1\">Abnormal renal tubular reabsorption&nbsp;&rarr; <strong>hyperphosphatemia</strong> &rarr; stimulation of parathyroid cells &rarr; elevated PTH</li>\n<li aria-level=\"1\">Increased <strong>FGF-23</strong> secretion from osteocytes &rarr; &nbsp;decreased 1,25 dihydroxyvitamin D &rarr; decreased intestinal absorption of calcium &rarr; elevated PTH</li>\n<li aria-level=\"1\">Normally, ECF calcium controls PTH secretion by interacting with CaSR. Stimulation of CaSR by high calcium suppresses PTH secretion. In chronic renal disease, there is <strong>reduced expression of Vitamin D and CaSR</strong> by bones &rarr; increased skeletal resistance to PTH &rarr; elevated PTH.</li>\n</ul><hr><h3>Related Pearl: Parathyroid Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c6b63d4374934158b4021e7aa5b159f2x1200x1541.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3736",
      "difficulty": "hard"
    },
    {
      "text": "A 32-year-old female patient is undergoing focussed parathyroidectomy for parathyroid adenoma. According to the Miami criteria, for the resection to be considered adequate, the intraoperative drop in parathyroid hormone should be ______.",
      "choices": [
        {
          "id": 1,
          "text": "More than one third  the maximum preoperative value in 10min"
        },
        {
          "id": 2,
          "text": "More than one third  the maximum preoperative value in half an 30 min"
        },
        {
          "id": 3,
          "text": "More than half  the maximum preoperative value in 10min"
        },
        {
          "id": 4,
          "text": "More than half  the maximum preoperative value in 30 min"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Drop of parathyroid hormone to <strong>more than half the maximum</strong> value at <strong>10 min</strong> postresection is considered an adequate resection in a parathyroid adenoma by the <strong>Miami criteria</strong>.</p>\n<p>Most of the patients with primary hyperparathyroidism have <strong>single</strong> <strong>adenoma</strong>, and therefore undergo a <strong>focused</strong> or <strong>minimally invasive parathyroidectomy,</strong> where the localized abnormal parathyroid gland is removed. Once the gland is removed, the surgeon can ensure that there is no other hyperactive gland remaining by performing an intraoperative PTH assay for Miami criteria.</p>\n<p>It is based on the principle that the <strong>half-life</strong> of the PTH is<strong> 3-5 minutes</strong>. In a single-gland disease, once the gland is removed the PTH levels should drop to &gt;<strong>50% of the preoperative PTH level within 10 minutes</strong>. However, if there is no drop in PTH level, then a multi-gland disease is suspected and the surgery is converted to a <strong>bilateral neck exploration.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2054",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old woman presented with complaints of fatigue, vomiting, abdominal cramps and bone pain. She had undergone total parathyroidectomy and heterotopic autotransplantation for the same complaints 8 months ago. Sestamibi scan was done and found to be normal. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Perform Casanova test"
        },
        {
          "id": 2,
          "text": "Post her for bilateral neck exploration"
        },
        {
          "id": 3,
          "text": "Post her for radiotherapy"
        },
        {
          "id": 4,
          "text": "Label her as persistent hyperparathyroidism and start her on medical management"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>recurrent hyperparathyroidism</strong> which could be due to recurrence in the <strong>neck</strong> or <strong>graft</strong> (graft hyperplasia). The next step would be to perform <strong>Casnova test</strong> to differentiate between them, as Sestamibi scan has ruled out ectopic parathyroid.</p>\n<p>Casanova test involves <strong>selective venous sampling</strong> for<strong> PTH levels</strong> from neck veins and brachial veins. If PTH from the <strong>brachial</strong> venous sample is <strong>&gt;20 times</strong> that of <strong>neck</strong> vein sample, <strong>graft hyperplasia</strong> is confirmed.</p>\n<p><strong>Persistent</strong> parathyroidism is defined as hypercalcemia that fails to resolve after parathyroidectomy i.e. <strong>within 6 weeks</strong> of surgery. <strong>Recurrent</strong> parathyroidism is hyperparathyroidism that occurs after an intervening period of at least <strong>6 months</strong> of biochemically documented <strong>normocalcemia</strong>. Causes of persistent/recurrent hyperparathyroidism include:</p>\n<ul>\n<li>Ectopic parathyroid</li>\n<li>Unrecognized hyperplasia - graft site hyperplasia</li>\n<li>Missed adenoma in normal position</li>\n<li>Incomplete resection</li>\n<li>Familial hyperparathyroidism</li>\n<li>MEN-1 syndrome</li>\n</ul>\n<p>The image below summarises the management protocol for a case of persistent/recurrent hyperparathyroidism.<br /><br />*FHH stands for Familial hypocalciuric hypercalcemia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/79b71b8113c84ba6a42bf8da9c6b5a71x1280x2336.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9678",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are indications for surgical intervention of tertiary hyperparathyroidism except ____",
      "choices": [
        {
          "id": 1,
          "text": "Reduced serum phosphate"
        },
        {
          "id": 2,
          "text": "Nephrocalcinosis"
        },
        {
          "id": 3,
          "text": "Nodular hyperplasia of the parathyroid gland"
        },
        {
          "id": 4,
          "text": "Impaired graft function"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Reduced serum phosphate is not an indication for surgical intervention in tertiary hyperparathyroidism. </p>\n<p><strong>Renal transplantation</strong> in patients with chronic kidney diseases may be associated with <strong>autonomous</strong> <strong>functioning</strong> of the <strong>parathyroid</strong> gland. This is called <strong>tertiary</strong> hyperparathyroidism where there is <strong>hypercalcemic</strong> hyperparathyroidism.</p>\n<p>The <strong>indications</strong> for<strong> surgical intervention</strong> in tertiary hyperparathyroidism are as follows :</p>\n<ul>\n<li>Subacute severe hypercalcaemia (&gt;3 mmol/L)</li>\n<li>Impaired graft function</li>\n<li>Nodular hyperplasia of the parathyroid gland(s)</li>\n<li>Progressive symptoms for &gt;2 years following transplantation\n<ul>\n<li>Worsening bone disease - pain, fractures, bone loss</li>\n<li>Renal stones/nephrocalcinosis</li>\n<li>Soft tissue or vascular calcifications</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4264",
      "difficulty": "medium"
    },
    {
      "text": "A 75-year-old lady with type 2 diabetes mellitus, hypertension, and end-stage renal disease on hemodialysis presents with hypercalcemia, hyperphosphatemia, and elevated PTH. What is the treatment of choice in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Total parathyroidectomy without autotransplantation"
        },
        {
          "id": 2,
          "text": "Subtotal parathyroidectomy"
        },
        {
          "id": 3,
          "text": "Minimally invasive focussed parathyroidectomy"
        },
        {
          "id": 4,
          "text": "Medical management with cinacalcet"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient&rsquo;s <strong>long-standing renal failure</strong> and <strong>elevated calcium</strong>, <strong>phosphate</strong>, and <strong>PTH</strong> are suggestive of <strong>tertiary hyperparathyroidism</strong>. This form of hyperparathyroidism can be <strong>life-threatening</strong>, and <strong>all patients</strong> with it should be referred for <strong>surgical intervention</strong>.&nbsp;</p>\n<p>The surgical <strong>procedure of choice</strong> for tertiary hyperparathyroidism is <strong>subtotal parathyroidectomy</strong>. In subtotal parathyroidectomy, the <strong>affected glands are completely removed</strong> and the <strong>least affected gland is partially resected</strong>. &nbsp;</p>\n<p>Option A: Total parathyroidectomy <strong>without an autograft</strong> is <strong>not a treatment option</strong> due to the postoperative and persistent <strong>difficulties</strong> in managing the associated <strong>hypocalcemia.</strong></p>\n<p>Option C: Minimally invasive approaches commonly refer to the removal of a <strong>localized abnormal parathyroid gland</strong> through an incision less than 3cm in length. It is based on the principle that over 80% of individuals with primary hyperparathyroidism have a<strong> single adenoma</strong>.&nbsp;It is <strong>contraindicated</strong> in <strong>multi-glandular disease</strong>, <strong>lithium-induced hyperparathyroidism,</strong> and hyperparathyroidism associated with <strong>familial syndromes</strong>.</p>\n<p>Option D: <strong>Cinacalcet</strong> is a calcimimetic <strong>used in</strong> the treatment of <strong>secondary hyperparathyroidism</strong>. The use of calcimimetics in <strong>tertiary hyperparathyroidism</strong> remains controversial and has <strong>not been approved</strong> for this indication.</p><hr><h3>Related Pearl: Biochemical parameters in metabolic bone diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic bone disease</strong></p>\n</td>\n<td><strong>Calcium</strong></td>\n<td><strong>PTH</strong></td>\n<td><strong>Phosphate</strong></td>\n<td><strong>ALP</strong></td>\n</tr>\n<tr>\n<td>\n<p>Rickets / Osteomalacia</p>\n</td>\n<td>&nbsp;&darr;/N</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&darr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Primary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp;&nbsp;&nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Secondary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Tertiary hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>Osteoporosis</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; N</td>\n</tr>\n<tr>\n<td>\n<p>Paget's&nbsp;disease</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Osteopetrosis</p>\n</td>\n<td>&nbsp; &darr;/N</td>\n<td>&uarr;/N</td>\n<td>&nbsp; &nbsp; &darr;/N</td>\n<td>&nbsp; N</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;&uarr;: Increased,&nbsp;&nbsp;&darr;: Decreased, N: Normal</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4388",
      "difficulty": "hard"
    },
    {
      "text": "A 41-year-old man with a history of treatment for Hodgkin's lymphoma in childhood presents with severe abdominal cramps and right flank pain. He has a firm 2x2cm mass in the front of his neck. He has a Calcium of 15.2 mg/dl, normal TSH, markedly elevated PTH, and PGP9.5+ on immunohistochemistry. What is the leading cause of mortality in his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Metastasis"
        },
        {
          "id": 2,
          "text": "Cardiovascular disease"
        },
        {
          "id": 3,
          "text": "Tracheal compression"
        },
        {
          "id": 4,
          "text": "Hypercalcemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient presents with symptoms suggestive of <strong>primary hyperparathyroidism</strong>. With <strong>early-onset, neck mass</strong>, and positive IHC for <strong>PGP9.5+</strong>, it is concerning for <strong>parathyroid cancer</strong>. <strong>Hypercalcemia</strong> is the <strong>leading cause</strong> of morbidity and <strong>mortality</strong> in patients with parathyroid cancer.&nbsp;</p>\n<p>Parathyroid cancer is a <strong>rare</strong> malignancy and makes up 1% of cases of primary hyperparathyroidism. History of <strong>prior neck radiation</strong> is considered to be a<strong> risk factor.</strong> Patients usually present a decade earlier than primary hyperparathyroidism (5th - 6th decade), with an equal preponderance in males and females. Patients may present with a neck mass and severely elevated calcium and PTH levels.</p>\n<p><strong>Treatment</strong> is focused on <strong>controlling hypercalcemia</strong> and <strong>surgery</strong> is the mainstay.</p>\n<p>Option B: <strong>Cardiovascular disease</strong> is a major contributing cause of <strong>mortality</strong> in patients with <strong>hyperthyroidism </strong>and<strong>&nbsp;chronic kidney disease</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4379",
      "difficulty": "medium"
    },
    {
      "text": "In patients with parathyroid carcinoma, which of the following treatment modalities would you not consider?",
      "choices": [
        {
          "id": 1,
          "text": "Radiation therapy"
        },
        {
          "id": 2,
          "text": "Azidothymidine"
        },
        {
          "id": 3,
          "text": "En-bloc excision of the tumor and ipsilateral thyroid lobe with MRND"
        },
        {
          "id": 4,
          "text": "Etelcalcetide"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Etelcalcetide has no role in the treatment of parathyroid carcinoma. It is ineffective.</p>\n<p><strong>Etelcalcetide</strong> is a calcium-sensing receptor agonist used to treat <strong>secondary hyperparathyroidism</strong> in adult patients with <strong>chronic kidney disease&nbsp;</strong>undergoing dialysis.</p>\n<p><strong>Treatment </strong>modalities for<strong> parathyroid carcinoma:</strong></p>\n<ul>\n<li aria-level=\"1\">Surgical - Bilateral neck exploration + En-bloc excision of the tumor and ipsilateral thyroid lobe with/without MRND (Modified radical neck dissection) in presence of lymph node metastasis.</li>\n<li aria-level=\"1\">Pharmacological:\n<ul>\n<li aria-level=\"1\"><strong>Cinacalcet</strong> hydrochloride, a calcimimetic, can reduce PTH levels by directly binding to the CaSR (calcium-sensing receptor) cells on the parathyroid gland; used to <strong>control hypercalcemia</strong> in refractory parathyroid carcinoma.&nbsp;</li>\n<li aria-level=\"1\"><strong>Azidothymidine</strong> (telomerase inhibitor)</li>\n<li aria-level=\"1\"><strong>Octreotide</strong>&nbsp;</li>\n<li aria-level=\"1\">Anti-parathyroid hormone immunotherapy</li>\n</ul>\n</li>\n<li aria-level=\"1\">Radiation therapy - for unresectable disease or for palliation of bone metastases</li>\n</ul>\n<p><strong>Risk factors</strong> for parathyroid carcinoma incude:</p>\n<ul>\n<li>Radiation exposure</li>\n<li aria-level=\"1\">Hyperparathyroidism jaw bone syndrome&nbsp;</li>\n<ul>\n<li aria-level=\"2\">HPRT gene or parafibromin inactivation</li>\n</ul>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4729",
      "difficulty": "hard"
    },
    {
      "text": "A 34-year-old man presents with severe hypercalcemia. His father had similar complaints and was found to have hyperparathyroid-jaw tumour syndrome. Which of the following is pathognomonic of his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Cystic mandibular lesions"
        },
        {
          "id": 2,
          "text": "Ossifying jaw fibromas"
        },
        {
          "id": 3,
          "text": "Osteitis fibrosa cystica"
        },
        {
          "id": 4,
          "text": "Mandibular granulomas"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ossifying jaw fibromas</strong> are a <strong>pathognomonic</strong> feature of <strong>hyperparathyroid-jaw tumour syndrome</strong>.&nbsp;It arises due to inactivating mutations in the HRPT2 gene on chromosome 1 q21-32, encoding <strong>parafibromin.</strong></p>\n<p>It is a rare cause of primary hyperparathyroidism with an <strong>early onset (32 years)</strong> which presents with <strong>severe hypercalcemia</strong>. It is associated with an <strong>increased risk</strong> of <strong>parathyroid carcinoma</strong> and other conditions like polycystic kidney disease.<strong> Surgical intervention</strong> may be considered to remove all enlarged glands.</p>\n<p><strong>Osteitis fibrosa cystica</strong> is a feature of <strong>hyperparathyroidism</strong> but is not considered pathognomonic of any condition.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4383",
      "difficulty": "medium"
    }
  ]
}